// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "CS XL LC PMID COLUMN SHALL OPTIONAL CV organism part PP INCLUDING JA disease mass pooled sample depletion MS MAGE NCBI II TIP label PSI ISA DOID CF CLO HF CELL MIAME reduction reagent disease stage PO BE ENVO EXPRESS SH CID URI WARRANTIES BUT UBERON QY LIMITED ROW CT ancestry category AS NOTE EM VK EW PTM FOR TAB III HUPO BRENDA HEREIN EBI MOD characteristics COULD VCF individual alkylation reagent PS REQUIRES TO RIGHTS IDF OF THE INFRINGE WARRANTY SHOULD CL DISCLAIMS CN REQUIRED dissociation method NCE exclamation ... CPTAC MHC WILL PROTEOMICS EFO proteomics data acquisition method file your instrument replicate AC MC LI README NT MONDO PRIDE:0000659 fraction identifier PRM HCD INITIATIVE IAA SN MINOR RAW developmental stage collision energy TA BMC source name_ and _assay name SWATH biological replicate RFC DDA STANDARDS IS FDR data file TMT cleavage agent details MAJOR OR THAT spiked compound fractionation method IMPLIED BTO SRM PURPOSE MT DTT MAY SP NOT INFORMATION PARTICULAR SILAC USE organism ZFA MS:1001251 XML PATCH PEPTIDESEQ URL MUST ALL PMCID SDRF DJ technical replicate sample FITNESS RECOMMEND MERCHANTABILITY source name DIA cell type biosample accession number PRIDE age ANY sex RECOMMENDED ID PATO HANCESTRO HTML IMPORTANT"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "CS XL LC PMID COLUMN SHALL OPTIONAL CV organism part PP INCLUDING JA disease mass pooled sample depletion MS MAGE NCBI II label PSI ISA DOID CF CLO HF CELL MIAME reduction reagent disease stage PO BE ENVO EXPRESS SH CID URI WARRANTIES BUT UBERON QY LIMITED ROW CT ancestry category AS EM VK EW PTM FOR TAB III HUPO BRENDA HEREIN EBI MOD COULD VCF individual alkylation reagent PS REQUIRES TO RIGHTS IDF OF THE INFRINGE WARRANTY SHOULD CL DISCLAIMS CN REQUIRED dissociation method NCE ... CPTAC MHC WILL PROTEOMICS EFO proteomics data acquisition method instrument AC MC LI README NT MONDO PRIDE:0000659 fraction identifier PRM HCD INITIATIVE IAA SN MINOR RAW collision energy TA BMC SWATH biological replicate RFC DDA STANDARDS IS FDR data file TMT cleavage agent details MAJOR OR THAT spiked compound fractionation method IMPLIED BTO SRM PURPOSE MT DTT MAY SP NOT INFORMATION PARTICULAR SILAC USE organism ZFA MS:1001251 PATCH PEPTIDESEQ URL MUST ALL PMCID SDRF DJ technical replicate FITNESS RECOMMEND MERCHANTABILITY DIA cell type biosample accession number PRIDE age ANY sex RECOMMENDED PATO HANCESTRO HTML"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "organism part CL:0000624 MONDO:0004975 disease PATO:0000461 PATO:0001340 depletion UBERON:0000955 NCBI lib TIP DOID PATO:0000383 CL:0000913 CL:0000576 PO MONDO:0005138 UBERON CL:0000815 MONDO:0004946 CL:0000066 CL:0000233 ancestry category UBERON:0000948 UBERON:0002048 UBERON:0002097 NOTE CL:0000625 COVID MONDO:0005301 CL:0000236 disease model UBERON:0001977 UBERON:0002107 PTM PDX NSG MONDO:0005148 CL:0000788 individual enrichment process CL:0000235 CL:0000451 CL:0000232 UBERON:0001088 DSS SHOULD CL CL:0000057 exclamation CL:0000813 MONDO:0005180 EFO UBERON:0001359 compound MONDO CL:0000623 xenograft PATO:0000384 developmental stage biological replicate NK CML MONDO:0008383 CL:0000898 UBERON:0000178 MAY synthetic peptide APP UBERON:0001155 UBERON:0002113 CL:0000540 MONDO:0100096 organism CL:0000084 MONDO:0004989 CL:0000182 URL CSF MUST ALL SDRF UBERON:0000310 UBERON:0001969 source name MONDO:0005575 cell type MONDO:0005105 age sex ID PATO HANCESTRO CL:0000787 IMPORTANT"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "organism part CL:0000624 MONDO:0004975 disease PATO:0000461 PATO:0001340 depletion UBERON:0000955 NCBI DOID PATO:0000383 CL:0000913 CL:0000576 PO MONDO:0005138 UBERON CL:0000815 MONDO:0004946 CL:0000066 CL:0000233 ancestry category UBERON:0000948 UBERON:0002048 UBERON:0002097 CL:0000625 COVID MONDO:0005301 CL:0000236 disease model UBERON:0001977 UBERON:0002107 PTM PDX NSG MONDO:0005148 CL:0000788 individual enrichment process CL:0000235 CL:0000451 CL:0000232 UBERON:0001088 DSS SHOULD CL CL:0000057 CL:0000813 MONDO:0005180 EFO UBERON:0001359 compound MONDO CL:0000623 xenograft PATO:0000384 developmental stage biological replicate NK CML MONDO:0008383 CL:0000898 UBERON:0000178 MAY synthetic peptide APP UBERON:0001155 UBERON:0002113 CL:0000540 MONDO:0100096 organism CL:0000084 MONDO:0004989 CL:0000182 URL CSF MUST ALL SDRF UBERON:0000310 UBERON:0001969 source name MONDO:0005575 cell type MONDO:0005105 age sex ID PATO HANCESTRO CL:0000787"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C18058 NCIT:C14168 NCIT:C16358 NCIT:C18213 height organism part NCIT:C28077 NCIT:C71732 disease MONDO:0005300 prior treatment menopausal status NCIT:C81327 NCIT:C15329 II NCIT:C14167 tumor grade HANCESTRO:0009 MONDO:0002050 Dukes stage breast cancer subtype NCIT:C14169 NCIT:C15262 NCIT:C27971 disease stage PREFERRED CHEBI:6801 NCIT:C4870 HANCESTRO:0010 HANCESTRO:0006 ancestry category NOTE sampling time point diet NCIT:C28079 NCIT:C27966 HIPAA weight NCIT:C28076 NCIT:C15445 NCIT:C15632 NCIT:C62723 ER III NCIT:C53553 medication history treatment response MONDO:0004995 BMI NCIT:C65106 Ann Arbor stage alcohol consumption MONDO:0005148 pre-existing condition individual pregnancy status body mass index IV NCI NCIT:C53556 smoking status NCIT:C27970 treatment status NCIT:C28078 CHEBI:41774 TNM staging MONDO:0005044 dose exclamation HANCESTRO:0005 NCIT:C65108 MONDO:0011122 EFO NCIT:C65107 gestational age compound NCIT:C53554 NCIT:C15313 MONDO GDPR NCIT PR UO NCIT:C28054 ACE CHEBI:28748 TNM NCIT:C68804 NCIT:C18206 MONDO:0004979 NCIT:C53555 treatment ethnicity organism PD NCIT:C14174 CHEBI:27899 time post treatment AJCC SDRF NCIT:C81328 age secondary condition sex ID HANCESTRO IMPORTANT"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C18058 NCIT:C14168 NCIT:C16358 NCIT:C18213 height organism part NCIT:C28077 NCIT:C71732 disease MONDO:0005300 prior treatment menopausal status NCIT:C81327 NCIT:C15329 II NCIT:C14167 tumor grade HANCESTRO:0009 MONDO:0002050 Dukes stage breast cancer subtype NCIT:C14169 NCIT:C15262 NCIT:C27971 disease stage PREFERRED CHEBI:6801 NCIT:C4870 HANCESTRO:0010 HANCESTRO:0006 ancestry category sampling time point diet NCIT:C28079 NCIT:C27966 HIPAA weight NCIT:C28076 NCIT:C15445 NCIT:C15632 NCIT:C62723 ER III NCIT:C53553 medication history treatment response MONDO:0004995 BMI NCIT:C65106 Ann Arbor stage alcohol consumption MONDO:0005148 pre-existing condition individual pregnancy status body mass index IV NCI NCIT:C53556 smoking status NCIT:C27970 treatment status NCIT:C28078 CHEBI:41774 TNM staging MONDO:0005044 dose HANCESTRO:0005 NCIT:C65108 MONDO:0011122 EFO NCIT:C65107 gestational age compound NCIT:C53554 NCIT:C15313 MONDO GDPR NCIT PR UO NCIT:C28054 ACE CHEBI:28748 TNM NCIT:C68804 NCIT:C18206 MONDO:0004979 NCIT:C53555 treatment ethnicity organism PD NCIT:C14174 CHEBI:27899 time post treatment AJCC SDRF NCIT:C81328 age secondary condition sex ID HANCESTRO"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "CS XL SRM ELISA MT URI file uri fraction MS:1001306 UNIMOD:35 FTP SHOULD proteomexchange accession number PP MS:1001309 TOF SILAC LTQ REQUIRED UNIMOD:737 MS:1001251 NOTE exclamation KR MRM MS:1001303 URL UNIMOD:1 MS1 scan range MS ST UNIMOD:4 MS:1001313 UNIMOD proteomics data acquisition method instrument MUST AC MSD TIP NT TS UNIMOD:21 label PSI fraction identifier MGF SDRF scan window lower limit PRM CF technical replicate modification parameters fragment mass tolerance sample RAW MS:1001917 precursor mass tolerance MS2 analyzer type MOD scan window upper limit DIA TA cleavage agent details DDA PRIDE SCIEX PRIDE:0000663 MM RECOMMENDED ID TMT data file RPPA HF IMPORTANT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "CS XL SRM ELISA MT URI file uri MS:1001306 UNIMOD:35 FTP SHOULD proteomexchange accession number PP MS:1001309 TOF SILAC LTQ REQUIRED UNIMOD:737 MS:1001251 KR MRM MS:1001303 URL UNIMOD:1 MS1 scan range MS ST UNIMOD:4 MS:1001313 UNIMOD proteomics data acquisition method instrument MUST AC MSD TS NT UNIMOD:21 label fraction identifier PSI scan window lower limit MGF SDRF fragment mass tolerance PRM CF technical replicate modification parameters RAW MS:1001917 precursor mass tolerance MS2 analyzer type MOD scan window upper limit DIA TA cleavage agent details DDA PRIDE SCIEX PRIDE:0000663 MM RECOMMENDED ID TMT data file RPPA HF"
  }
];
